GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Other Gross PPE

Palisade Bio (STU:7NS0) Other Gross PPE : €0.01 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Other Gross PPE?

Palisade Bio's Other Gross PPE for the quarter that ended in Mar. 2024 was €0.01 Mil.

Palisade Bio's quarterly Other Gross PPE stayed the same from Sep. 2023 (€0.01 Mil) to Dec. 2023 (€0.01 Mil) but then declined from Dec. 2023 (€0.01 Mil) to Mar. 2024 (€0.01 Mil).

Palisade Bio's annual Other Gross PPE increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.01 Mil) but then declined from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€0.01 Mil).


Palisade Bio Other Gross PPE Historical Data

The historical data trend for Palisade Bio's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Other Gross PPE Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Gross PPE
- - 0.01 0.01

Palisade Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Palisade Bio Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Palisade Bio (STU:7NS0) Business Description

Traded in Other Exchanges
Address
5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines